SEC62 and prostate carcinoma: Subsequent studies identified SEC62 overexpression as a phenomenon associated with prostate cancer progression in patients and, in prostate cancer cells, as the reason for increased ER stress tolerance as well as increased migratory and invasive potential (Greiner et al., 2011a; Greiner et al., 2011b).